Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.6100 (-2.43%) ($5.5400 - $6.0000) on Mon. Apr. 15, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.07% (three month average) | RSI | 53 | Latest Price | $5.6100(-2.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 2.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) VXX(87%) PCY(12%) XBI(11%) LIT(10%) EWY(9%) | Factors Impacting CAPR price | CAPR will decline at least -3.035% in a week (0% probabilities). URA(-23%) XLE(-16%) USO(-16%) BLOK(-16%) XOP(-15%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.035% (StdDev 6.07%) | Hourly BBV | 0 () | Intraday Trend | -3.3% | | | |
|
Resistance Level | $5.73 | 5 Day Moving Average | $5.77(-2.77%) | 10 Day Moving Average | $5.87(-4.43%) | 20 Day Moving Average | $5.73(-2.09%) | To recent high | -17.5% | To recent low | 12.2% | Market Cap | $111m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |